A three filament mechanistic model of musculotendon force and impedance
eLife · 2024
DOI: 10.7554/elife.88344 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Matthew Millard und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Sport and Movement Science, University of Stuttgart, Stuttgart, Germany. Hauptthemen laut MEDLINE: Models, Biological. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Bayerische Staatsministerium für Wirtschaft, Landesentwicklung und Energie, Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
The force developed by actively lengthened muscle depends on different structures across different scales of lengthening. For small perturbations, the active response of muscle is well captured by a linear-time-invariant (LTI) system: a stiff spring in parallel with a light damper. The force response of muscle to longer stretches is better represented by a compliant spring that can fix its end when activated. Experimental work has shown that the stiffness and damping (impedance) of muscle in response to small perturbations is of fundamental importance to motor learning and mechanical stability, while the huge forces developed during long active stretches are critical for simulating and predicting injury. Outside of motor learning and injury, muscle is actively lengthened as a part of nearly all terrestrial locomotion. Despite the functional importance of impedance and active lengthening, no single muscle model has all these mechanical properties. In this work, we present the viscoelastic-crossbridge active-titin (VEXAT) model that can replicate the response of muscle to length changes great and small. To evaluate the VEXAT model, we compare its response to biological muscle by simulating experiments that measure the impedance of muscle, and the forces developed during long active stretches. In addition, we have also compared the responses of the VEXAT model to a popular Hill-type muscle model. The VEXAT model more accurately captures the impedance of biological muscle and its responses to long active stretches than a Hill-type model and can still reproduce the force-velocity and force-length relations of muscle. While the comparison between the VEXAT model and biological muscle is favorable, there are some phenomena that can be improved: the low frequency phase response of the model, and a mechanism to support passive force enhancement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Sport and Movement Science, University of Stuttgart, Stuttgart, Germany.
- Institute of Engineering and Computational Mechanics, University of Stuttgart, Stuttgart, Germany.
- Neuromuscular Diagnostics, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.
- Munich School of Robotics and Machine Intelligence (MIRMI), Technical University of Munich, Munich, Germany.
- Munich Data Science Institute (MDSI), Technical University of Munich, Munich, Germany.
- Human Performance Laboratory, University of Calgary, Calgary, Canada.
ORCID-Profile: Matthew Millard, David W Franklin, Walter Herzog
Förderung
- Deutsche Forschungsgemeinschaft
- Bayerische Staatsministerium für Wirtschaft, Landesentwicklung und Energie
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Millard, M., Franklin, D. W., & Herzog, W. (2024). A three filament mechanistic model of musculotendon force and impedance. eLife. https://doi.org/10.7554/elife.88344
Vancouver
Millard M, Franklin DW, Herzog W. A three filament mechanistic model of musculotendon force and impedance. eLife. 2024. doi:10.7554/elife.88344
BibTeX
@article{Millard2024,
author = {Millard, Matthew and Franklin, David W and Herzog, Walter},
title = {A three filament mechanistic model of musculotendon force and impedance},
journal = {eLife},
year = {2024},
doi = {10.7554/elife.88344}
}
EUVIMED